Dr. Michael D. Rokaw, MD

Internal Medicine Doctor
Nephrologist

Request an Appointment with Dr. Michael Rokaw

Dr. Rokaw practices Internal Medicine and Nephrology in Shreveport, Louisiana.

Physician Profile for Dr. Michael D. Rokaw, MD

Addresses:: 1800 Buckner Street; Shreveport, LA 71101; 3300 Al Bicknell Drive; Shreveport, LA 71103

Personal Facts

Personal Facts:: Accepting New Patients: Yes; Male; Years Since Graduation: 21; Practice Member Since: 1999.; Current Title: Nephrologist
Awards and Honors:: 2004, Fellow American Society Nephrology; 1991, outstanding teaching resident award-University of Pittsburgh; 1995, National Kidney Foundation Young Investigator Grant Recipient; 2004,2005, On list of Shreveport/Bossier Best Physicians-SB Magazine
: HealthGrades Recognized Doctors are board certified in the specialty they practice; have never had their license restricted or revoked; are free of state or federal disciplinary actions; and are free of any malpractice claims.
Professional Appointments:: Assistant Professor of Medicine University of Pittsburgh
Professional Affiliations/Memberships:: 1991, FASN, American Society of Nephrology; 2004, American College of Physicians; 1999, National Kidney Foundation
Publications:: 1998, A second enzyme protecting mineralocorticoid receptors from glucocorticoid, Am. Journal of Physiology
Morris, D.J., Latif, S.A., Rokaw, M.D., Watlington, C.O., Johnson, J.P. A second enzyme protecting mineralocorticoid receptors from glucocorticoid Occupancy. Am. J. Physiol C1245-52 (1998); 1996, Rapamycin inhibits Protein Kinase C activity and stimulates sodium transport in A6 cells, Journal Biological Chemisty
Michael D. Rokaw, and John P. Johnson. Rapamycin inhibits Protein Kinase C activity and stimulates sodium transport in A6 cells. J. Biol chem 271:32468-32479 (1996); 1998, CarboxylMethylation of the Beta subunit of XeNaC regulates, J. Biol Chem273
CarboxylMethylation of the Beta subunit of XeNaC regulates Channel activity A6. 1. Michael D. Rokaw, J. Wang, R. Edinger, O.A. Weisz, D. Hui,P. Middleton, V. Shylyonsky, B.K. Berdiev, D. Eaton, I. Ismailov, D. Eaton, D. Benos, J.P. Johnson.; 1996, FK506 and rapamycin, but not cyclosporin inhibit aldosterone stimulated sodium transport in A6 cells, Am. J. Physiology
Michael D. Rokaw, Michael West, Paul M. Palevsky, John P. Johnson. Amer. J. Physiol: Cell Physiology. C194-202; 1996, Regulation of a sodium channel associated G-protein by aldosterone., J. Biol. Chem.
Michael D. Rokaw, Dale J. Benos, Paul M. Palevsky, Sonia A. Cunningham, Michael E. West, and John P. Johnson.; 1996, Chronic regulation of transepithelial Na+ transport by the rate of apical Na entry., Am. J. Physiol
Michael D. Rokaw, Erdal Sarac, Eric Lechman, Michael West, Joseph Angeski, John P. Johnson, and Mark L. Zeidel.; 1996, Differential glycosylaion of MUC1., Glycogenate Journal
Poland, P.A., Kinlugh, C.L., Rokaw, M.D., Margarian-Blander, J., Finn, O.J.,and Hughey, R.P.,; 1999, Vasopression stimulates sodium transport in A6 via a phosphatidylinoside-3-kinase dependent pathway, Am. J. Physiology
Edinger, R.S., Rokaw, M.D., Johnson, J.P.,; 1995, “Experimental Acute Renal Failure” in Update in Intensive Care and Emergency Medicine (20) – Acute Renal Failure in the Critically Ill., Acute Renal Failure in the Critically Ill. Claudio Ronco and Rinaldo Bellomo, editors. Springer (1995)
John P. Johnson and Michael D. Rokaw: Claudio Ronco and Rinaldo Bellomo, editors. Springer; 1995, Sepsis or ischemia in experimental acute renal failure: What have we learned?, New Horizons Vol 3 No 4 608-613
John P. Johnson and Michael D. Rokaw:
Newspaper:: 7/12/05, local state numbers of kidney diseases rise, Shreveport Times
Patients with Chronic Kidney disease and End Stage Kidney Disease rising in Caddo and across the United States. This is in part secondary to the diabetes and obesity epidemic.
Professional Interests:: Electrolyte disorders, dialysis, Chronic Kidney Disease
Physician Treats:: Anemia, Electrolyte disorder, Hyperparathyroidism, Hypertension (High Blood Pressure), Renal (Kidney) Diseases & Disorders, Renal (Kidney) Failure, Renal Lithiasis (Kidney Stones), Sarcoid, Sjogren's syndrome, Systemic lupus, Systemic sclerosis

Patient / Medical Philosophy: Prevent Progression of Chronic Kidney Disease. Optimize care for Chronic Kidney Disease by managing hypertension, anemia, secondary hyperparathyroidism, diabetes, immunizations. Follow NKF K/DOQI guidelines. Recognize high association of Chronic Kidney Disease with Cardiovascular disease and aggressively identify and treat risk factors. Work closely with cardiology and vascular physicians.

Experience / Training

Specialties:: Internal Medicine; (HealthGrades has verified that Dr. Michael D. Rokaw, MD is board certified by the American Board of Internal Medicine); Information from ABMS® is proprietary data maintained in a copyrighted database compilation owned by the American Board of Medical Specialties®. © Copyright 2009 American Board of Medical Specialties. All rights reserved.; Nephrology; (HealthGrades has verified that Dr. Michael D. Rokaw, MD is board certified by the American Board of Internal Medicine); Information from ABMS® is proprietary data maintained in a copyrighted database compilation owned by the American Board of Medical Specialties®. © Copyright 2009 American Board of Medical Specialties. All rights reserved.

Medical School:: Suny Buffalo
Buffalo, NY 1988
Internship:: University Pittsburgh
Pittsburgh, PA
Residency:: University Pittsburgh
Pittsburgh, PA
Fellowship:: University Pittsburgh
Pittsburgh, PA
Positions:: University Pittsburgh
Pittsburg, PA

Disciplinary Actions: HealthGrades has examined disciplinary actions within the last five years from the Office of Inspector General and 50 state medical boards.
HealthGrades could not detect any disciplinary actions for Dr. Michael D. Rokaw, MD as of 07/10/2009.
Note: HealthGrades reports on state and federal disciplinary actions (if any) from the previous five years.

Malpractice History: HealthGrades did not find any closed malpractice claims for Dr. Michael D. Rokaw, MD in the states of California, Connecticut, Florida, Georgia, Idaho, Indiana, Massachusetts, Maryland, North Dakota, New Jersey, New York, Oregon, Tennessee, Texas, Virginia, Vermont, or West Virginia. Learn More

Note: HealthGrades obtains physician information from a variety of sources. Some information that is not designated as HealthGrades verified has been reported by the physician.